LifeVent EVO Ventilator, 02 - Model Number: SP2100X26B Trilogy Evo is intended for pediatric t...

FDA Device Recall #Z-0954-2020 — Class I — November 19, 2019

Recall Summary

Recall Number Z-0954-2020
Classification Class I — Serious risk
Date Initiated November 19, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips Respironics, Inc.
Location Murrysville, PA
Product Type Devices
Quantity 29

Product Description

LifeVent EVO Ventilator, 02 - Model Number: SP2100X26B Trilogy Evo is intended for pediatric through adult patients weighing at least 2.5 kg. The ventilator can measure, display, record, and alarm SpO2, FiO2, CO2, and Pulse Rate data when integrated with the appropriate accessories.

Reason for Recall

Software defect in the Trilogy EVO and Trilogy EVO Universal Ventilator, versions SW 1.00.05, SW 1.01.09.00, SW 1.01.10.00, and SW 1.01.11.00, causing inoperative and loss of all power alarms. This defect causes an incorrect or unexpected result failing requirements TSRS1298 and PRD439.

Distribution Pattern

US: None OUS: CH DE DK IT FR IE GB KW QA PL ES AT PH AE SI CZ

Lot / Code Information

Model/Material Number: SP2100X26B Serial Numbers: H25538574D9D9, H256917933B78, H2569193868C0, H2569196907F1, H25691987749F, H256920522A99, H2569224829A3, H256924542CCE, H256925062BB8, H25692591881F, H25692661E4B3, H25692712C1FC, H25692910F2F5, H25692952B687, H256930400CE8, H25693118A4C4, H2569421090C9, H256943094E0C, H25755370F165, H25755371E0EC, H25755372D277, H25769443EF6B, H2576945959E9, H2576949608BE, H25769512DA86, H25769515AE39, H257695178D2B, H257699654692, H25772204E13C,

Other Recalls from Philips Respironics, Inc.

Recall # Classification Product Date
Z-1617-2026 Class I Philips Respironics Trilogy Evo Universal, Soft... Mar 2, 2026
Z-1615-2026 Class I Philips Respironics Trilogy Evo O2, Software Ve... Mar 2, 2026
Z-1616-2026 Class I Philips Respironics Trilogy EV300, Software Ver... Mar 2, 2026
Z-1614-2026 Class I Philips Respironics Trilogy Evo, Software Versi... Mar 2, 2026
Z-0481-2026 Class II SimplyGo Mini, Standard Battery Kit; Product c... Oct 7, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.